Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p 0.0001) ...

A larger percentage of patients in PFA group had treatment success at 12 months compared with those receiving antiarrhythmic-drug therapy.

Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting ...

A pacemaker may be useful for atrial fibrillation (AFib) involving a slow heart rate or other heart conduction disorders. However, doctors may recommend lifestyle changes to manage AFib before a ...

Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation ...

Atrial fibrillation is the most common cardiac arrhythmia worldwide and prevalence is expected to continue rising at an exponential rate with an aging population and increasing rates of obesity and ...

A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced ...